We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Screening Strategies in Drug Discovery – News and Features

Gloved hand holding a 96 well plate in front of a screen displaying qPCR amplification curves.
Article

qPCR vs dPCR: Choosing the Right PCR Technology To Suit Your Experimental Needs

How can you identify which technique is best suited to your research requirements? In this article, we explore the advantages of qPCR and dPCR, considering specific applications and deliverable metrics to help you choose the right technology to suit your experimental needs.
A crystal structure of a molecular lattice.
News

Scientists Discover a New Type of Porous Material That Can Store Greenhouse Gases

Researchers have used computer modeling to develop a new type of porous material that can capture and store greenhouse gases.
Illustration of a human form
Article

Dissecting the Proteome To Understand Disease

Proteomics provides insights into the regulation of biological processes and mechanisms of disease. In this article, we explore approaches scientists are using to find early markers of disease, new drug targets and strategies to overcome resistance to treatments.
A lab worker pipetting media into a cell culture dish.
Industry Insight

Recreating Organ-Specific Tumor Environments In Vitro

At ELRIG’s Research & Innovation 2024 event, Technology Networks spoke to Dr. Véronique De Conto, project leader in in vitro pharmacology at HCS Pharma, to learn more about their powerful tools for in vitro metastasis propagation.
The outline of a person and their brain facing a cannabis leaf and symbolic CBN pill.
News

Cannabinols Show Neuroprotective Properties in Fruit Flies

Salk scientists observe cannabinol's neuroprotective properties in fruit flies and identify cannabinol analogs that could serve as promising future therapeutics for traumatic brain injury, Alzheimer's, and Parkinson's.
A group of scientists discussing.
Industry Insight

Breaking Barriers: The Challenges Faced by 6 Biotech Start-Ups in 2024

At the European Laboratory Research and Innovation Group’s (ELRIG) Research and Innovation 2024 event, we asked a selection of start-up companies in the biotech space the same question: what are the key challenges you currently face?
Ocular Fibrosis, 3D Cell Culture Image, spherical microscopy image with various colors.
Industry Insight

Bridging Academia and Industry: The Evolution of 3D Models in Drug Development

The industry's search for alternatives to traditional preclinical drug testing methods has led to a growing interest in the potential of three-dimensional (3D) in vitro models. To delve deeper into this subject, Technology Networks spoke with Madhu Lal-Nag, chief scientific officer at InSphero, a 3D in vitro model company with a mission to “modernize drug discovery in ways that inspire researchers everywhere to reach their full potential and fuel a new era of breakthrough therapies.”
A row of pipettes filled with red liquid
Article

High-Throughput Screening: Advances, Applications and Combined Approaches

In this article, we highlight various high-throughput screening strategies being used to interrogate large libraries of compounds and hear from researchers working to further streamline specific approaches to increase speed and improve quality and accuracy.
Various pills on a table with a magnifying glass over one, bringing into focus.
Article

Drug Repurposing Strategies, Challenges and Successes

In this article, we explore the evolution of drug repurposing from a serendipitous occurrence to a more formalized endeavor involving advanced computational approaches and bioengineered test beds, considering its advantages, challenges and successes.
A selection of pills and capsules in different shapes and colors.
News

Streamlined Drug Discovery Approach Proposed by Researchers

New research points to a streamlined approach to drug discovery that allows drug makers to determine the viability of a fragment-based design earlier in the process.
Advertisement